Fulcrum Therapeutics Inc (FULC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 22,186 | 22,693 | 21,858 | 19,815 | 20,403 |
| Operating Income | -22,186 | -22,693 | -21,858 | -19,815 | -20,403 |
| Other Income | 3,295 | 2,359 | 2,263 | 2,519 | 2,748 |
| Pre-tax Income | -18,891 | -20,334 | -19,595 | -17,296 | -17,655 |
| Net Income Continuous | -18,891 | -20,334 | -19,595 | -17,296 | -17,655 |
| Net Income | $-18,891 | $-20,334 | $-19,595 | $-17,296 | $-17,655 |
| EPS Basic Total Ops | -0.25 | -0.31 | -0.31 | -0.28 | -0.28 |
| EPS Basic Continuous Ops | -0.25 | -0.31 | -0.31 | -0.28 | -0.28 |
| EPS Diluted Total Ops | -0.25 | -0.31 | -0.31 | -0.28 | -0.28 |
| EPS Diluted Continuous Ops | -0.25 | -0.31 | -0.31 | -0.28 | -0.28 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.31 | -0.31 | -0.28 | -0.28 |
| EBITDA(a) | $-21,848 | $-22,346 | $-21,512 | $-19,471 | $-20,050 |